Prosecution Insights
Last updated: August 06, 2026
Application No. 17/320,757

COMPOSITION FOR GROWTH STIMULATION AND RESISTANCE TO STRESS FACTORS FOR PLANTS OF THE CANNABACEAE FAMILY

Final Rejection §112
Filed
May 14, 2021
Priority
May 15, 2020 — provisional 63/025,390
Examiner
AZPURU, CARLOS A
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Psimos Inc.
OA Round
5 (Final)
84%
Grant Probability
Favorable
6-7
OA Rounds
0m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
1081 granted / 1290 resolved
+23.8% vs TC avg
Moderate +11% lift
Without
With
+10.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
34 currently pending
Career history
1314
Total Applications
across all art units

Statute-Specific Performance

§101
2.7%
-37.3% vs TC avg
§103
24.5%
-15.5% vs TC avg
§102
20.0%
-20.0% vs TC avg
§112
30.4%
-9.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1290 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Receipt is acknowledged of the amendment filed 07/14/2026. Maintained Rejection(s) The rejections under 35 USC 112, first and second paragraph for claims 1, 3, 4, 15-17, 19-24. Response to Arguments Applicant's arguments filed 07/14/2026 have been fully considered but they are not persuasive. With regard to the rejection under 35 USC 112, first paragraph, applicant point to {0023} for support. PNG media_image1.png 274 639 media_image1.png Greyscale While pointing out propane-1,2,3-trio or propane-1,2,-diol, the paragraph also includes “any other suitable alcohol”. This is not a definition of the alcohols intended for use in the invention because it includes two specific diols, and then the broad terminology including “any other suitable alcohol”. Amendment is advised to site the two specific diols contemplated by the specification to overcome this rejection. Regarding 35 USC 112, second paragraph, amendment of claim 2 does not correct the deficiency of the remainder of the claims (claims 1, 3, 4, 15-17, and 19-24). That is the metes and bounds of the term “alcohol” are not readily apparent. Applicant is requested to amend claim 1 to include the two specific diols cited by the specification to overcome this rejection. Conclusion No claims are allowed. Claim 2 is objected as depending upon a rejected base claim. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to CARLOS A AZPURU whose telephone number is (571)272-0588. The examiner can normally be reached 9 am- 3 pm, 4 pm-8pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sue X Liu can be reached at 571-272-5539. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CARLOS A AZPURU/Primary Examiner, Art Unit 1617 caz
Read full office action

Prosecution Timeline

Show 20 earlier events
Dec 23, 2025
Response after Non-Final Action
Feb 25, 2026
Request for Continued Examination
Mar 03, 2026
Response after Non-Final Action
Mar 17, 2026
Non-Final Rejection mailed — §112
May 14, 2026
Examiner Interview Summary
May 14, 2026
Applicant Interview (Telephonic)
Jul 14, 2026
Response Filed
Jul 28, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12685758
COMPOSITIONS AND METHODS FOR INHIBITING THE BIOLOGICAL ACTIVITY OF SOLUBLE BIOMOLECULES
2y 11m to grant Granted Jul 21, 2026
Patent 12678448
POLYMERIC CARRIERS FOR DELIVERY OF THERAPEUTIC AGENTS
3y 6m to grant Granted Jul 14, 2026
Patent 12678536
BIOCOMPATIBLE POLYMER, BIOCOMPATIBLE COMPOSITIONS, SOL OR GEL, AND INJECTABLE COMPOSITION
3y 4m to grant Granted Jul 14, 2026
Patent 12673134
GELATIN-CONTAINING DEVICE
2y 11m to grant Granted Jul 07, 2026
Patent 12667545
Lyophilized Compositions of Phenobarbital Sodium Salt
4y 0m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

6-7
Expected OA Rounds
84%
Grant Probability
94%
With Interview (+10.6%)
2y 7m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1290 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month